Linin

Quick links to important sections

Linin

Selected form

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Linin

What is Linin? Quick Overview

Here is a quick reference guide to the core identity of Linin (Linaclotide).

Property Description
Active Ingredient Linaclotide
Form Oral Capsule
Pharmacological Class Guanylate Cyclase-C (GC-C) Agonist
Route of Administration Oral
Origin Synthetic Peptide

What Type of Medicine is Linin?

Linin is the brand name for the prescription medicine Linaclotide, an oral capsule used to manage chronic gastrointestinal issues by acting locally in the gut. Its active ingredient, Linaclotide, is classified as a Guanylate Cyclase-C (GC-C) Agonist, representing a specific class of medicine clinically recognized for selectively modulating intestinal receptors. Linaclotide is a synthetic peptide. This means the drug is chemically manufactured, and its structure is a small protein chain.

Linin’s Composition and Local Action

Linin is designed to remain localized to the digestive tract with minimal absorption into the bloodstream. The medication is taken as a simple, oral capsule containing the single active ingredient, Linaclotide. Because the drug molecule is large, it is poorly absorbed, which is a key design feature. The drug shows minimal systemic absorption. This provides assurance that the medication's primary action is focused on the intestines, limiting its potential circulation throughout the rest of the body.

What is the General Purpose of Linin?

The general purpose of Linin is to help regulate bowel function and provide relief from abdominal discomfort. It is considered a localized, dual-action solution because its activity encourages the natural secretion of fluid into the intestine, which helps soften stool and promote easier passage. Additionally, its action is known to modulate pain signals from nerves in the gut wall. This mechanism gives it a unique benefit in addressing both movement and sensory issues in the digestive system, making it a recognized option for managing persistent digestive discomfort.

What side effects are possible with Linin?

Possible Side Effects and Safety Information

Linin (Linaclotide) has an official safety profile primarily characterized by adverse reactions affecting the gastrointestinal system, which is consistent with its localized action within the gut. Adverse reactions are classified by regulatory authorities based on their observed frequency in clinical studies.

Frequency-Classified Adverse Reactions

Classification Examples of Reactions
Very Common (Affects more than 1 in 10) Diarrhea
Common (Affects up to 1 in 10) Abdominal pain, Abdominal distension (bloating), Flatulence, Nausea, Viral gastroenteritis
Uncommon (Affects up to 1 in 100) Dehydration, Vomiting, Urticaria (hives), Gastrointestinal hemorrhage

Serious adverse reactions documented in regulatory sources include severe diarrhea, which may lead to dehydration, classified as a Metabolism and Nutrition Disorder. Serious hypersensitivity reactions, such as angioedema, are listed as rare Immune System Disorders.

Population-Specific Safety Constraints

Safety labels establish specific limitations for certain groups. The medicine is contraindicated in children under 6 years of age, and use is not recommended in patients aged 6 to 17 years due to the potential for serious dehydration. For older adults, there may be an increased risk of dehydration following diarrhea. No dose adjustment is required for patients with renal or hepatic impairment due to the drug's minimal systemic absorption.

Furthermore, regulatory documents specify that the most frequent side effect, diarrhea, typically appears early in the course of treatment, with the highest incidence reported within the first two weeks of initiating therapy. Linin is also contraindicated in patients with known or suspected mechanical gastrointestinal obstruction.

Overdose and Emergency Response

Linin Overdose and When to Seek Help

Linin (linaclotide) acts locally in the gastrointestinal tract and is minimally absorbed into the bloodstream. As a result, the risk of a typical systemic overdose is considered low. However, taking more than the prescribed dosage can significantly increase the occurrence and severity of its primary side effect, diarrhea.

Symptoms of Overdose

The main symptom associated with taking too much Linin is severe and frequent diarrhea. This can lead to serious complications related to fluid and electrolyte imbalance. Symptoms of potential severe dehydration resulting from excessive diarrhea include:

  • Severe thirst or dry mouth
  • Dizziness or lightheadedness
  • Reduced urination
  • Unusual fatigue or weakness

When to Seek Emergency Help

An overdose of Linin requires immediate medical attention to manage dehydration and electrolyte loss. Call emergency services or the Poison Control Center immediately if you or someone else has taken more than the recommended dose, even if no symptoms are immediately apparent.

Seek emergency care right away if you experience any of the following:

  • Diarrhea that is severe and persistent, or watery diarrhea with blood.
  • Signs of severe dehydration (fainting, confusion, or extreme dizziness).
  • Severe, unusual, or worsening abdominal pain.

Therapeutic Uses of Linin

What Linin Treats: Main Uses and Benefits

Linin is a supportive medication focused on providing symptomatic relief across various clinical contexts, following general principles of symptom management. It is generally used in situations involving symptomatic discomfort and is applied when temporary assistance for symptom management is needed.

Therapeutic Applications

Linin is relevant across domains where additional symptomatic support is needed, particularly for conditions characterized by episodic or fluctuating symptom patterns. This medication helps address symptom clusters that may appear suddenly or intensify over time, helpful in situations where multiple symptoms occur together and create noticeable functional strain. It is commonly used when short-term symptomatic assistance is needed during phases where symptoms become momentarily overwhelming.

“The medication is used in situations involving certain distressing symptoms, applying symptomatic support during periods of increased discomfort or tension.”

The medication is applicable in clinical settings that involve acute or unstable symptom patterns, offering support that helps ease the overall burden of symptoms and may help patients cope more steadily with symptom fluctuations, including situations where discomfort is interfering with daily stability and creating temporary functional strain.

Quick Takeaway

Quick Fact: Supports Management of Episodic Discomfort

Linin contributes to easing the overall symptom load during periods of heightened symptoms and supports patients during difficult episodes.

Regulatory References

  1. NHS Guide to Symptom Management

Eligibility and Restrictions for Use

Who Can and Cannot Use Linin?

The eligibility for Linin (Linaclotide) is strictly defined by regulatory criteria regarding patient age and specific medical conditions.

Populations Who Must Not Use Linin (Contraindications)

Linin is strictly contraindicated for two major groups. The medicine must not be used in patients less than 2 years of age, a restriction imposed due to the risk of serious dehydration. Use is also prohibited in patients who have a known or suspected mechanical gastrointestinal obstruction. Additionally, the medicine is contraindicated in individuals with a hypersensitivity to linaclotide or any of its components.

Approved Age and Condition Restrictions

Linin is approved for adults (18 years and older) in both the US and EU. In the US, it is also approved for certain pediatric patients: those 6 years and older for Functional Constipation, and those 7 years and older for Irritable Bowel Syndrome with Constipation. However, its use is not recommended in children and adolescents under 18 in the European Union.


Population Status Regulatory Rule
Pregnancy/Lactation Use is not recommended or should be avoided.
Renal/Hepatic Impairment No dose adjustment is required.
Inflammatory Bowel Conditions Use is not recommended (lack of study data).

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information for Linin (Linaclotide) establishes its interaction profile based primarily on its localized activity in the gastrointestinal (GI) tract and its minimal systemic absorption. Due to the lack of measurable systemic exposure, systemic pharmacokinetic interactions are not expected. Regulatory data confirms Linaclotide is neither an inhibitor nor an inducer of the Cytochrome P450 (CYP) enzyme system or P-glycoprotein (P-gp) transporters.

Pharmacodynamic and Indirect Interactions

Co-administration with other substances that affect GI function may increase the risk of diarrhea. Medicinal products identified in this category include Laxatives, Proton Pump Inhibitors (PPIs), and Non-Steroidal Anti-Inflammatory Drugs (NSAIDs).

Severe or prolonged diarrhea may lead to an indirect absorption interaction, where accelerated GI transit reduces the absorption and efficacy of certain co-administered oral medicines. This risk is specifically noted for Oral Contraceptives and oral medicinal products with a Narrow Therapeutic Index (NTI), such as Levothyroxine.

Timing and Population Notes

The medicine's effect profile is sensitive to co-administration timing with meals. The medicine must be administered on an empty stomach at least 30 minutes before the first meal of the day, as taking it with a high-fat meal can result in looser stools. Although no formal interaction is documented, elderly patients (aged 65 years and older) have a higher risk of developing diarrhea, which increases the potential clinical significance of the indirect absorption interaction.

Mechanism of Action

Linin's pharmacodynamic action is entirely peripheral and involves the simultaneous influence of the molecule on both intestinal fluid balance and visceral sensory signaling within the gut wall. The mechanism initiates as a highly selective agonist of the Guanylate Cyclase-C (GC-C) receptor on the luminal surface of intestinal epithelial cells. This binding activates the intracellular cGMP signaling pathway, which subsequently triggers the opening of the CFTR ion channel . This cascade facilitates the secretion of chloride and bicarbonate ions into the lumen. This ionic flux drives the osmotic movement of water into the intestine, resulting in increased fluid volume and faster transit of contents within the gastrointestinal tract.

In addition, a portion of the resulting intracellular cGMP is extruded into the submucosal space. This external cGMP acts upon nearby nociceptors (pain-sensing nerves) located beneath the epithelial lining, decreasing their excitability. By dampening the activity of these peripheral sensory nerves, the molecule modulates peripheral visceral nociceptive signaling. This reduction in nerve excitability contributes to the sensory component of the drug’s dual physiological action.

Dosage and Administration Information

How Linin is Used: Official Administration Guidelines

Linin (Linaclotide) is prescribed for oral administration and is available in fixed microgram strengths of 72 mug, 145 mug, and 290 mug. The standard regimens are defined by the specific indication: 290 mug once daily for adults with Irritable Bowel Syndrome with Constipation (IBS-C), and typically 145 mug once daily for Chronic Idiopathic Constipation (CIC). The lower 72 mug strength may also be used once daily for CIC based on individual needs.

Administration Requirement Official Instruction
Frequency and Timing Taken once daily at approximately the same time each day. Must be taken on an empty stomach, at least 30 minutes prior to the first meal of the day.
Preparation and Handling The capsule must be swallowed whole. It must not be crushed, broken, or chewed. The medicine can be administered via nasogastric or gastrostomy tube by suspending the contents in water for immediate use.
Dose Adjustment Guidance No dose adjustment is required for patients with renal or hepatic impairment. Specific pediatric doses are defined for Functional Constipation (FC) and pediatric IBS-C.

Use Protocol

The overall use protocol is structured around consistent daily intake and strict adherence to timing. If a dose is missed, the instruction is to skip the missed dose and take the next dose at the regularly scheduled time; double dosing is not permitted. The need for continued Linin use should be periodically assessed by the prescribing physician.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Linin


1. Research Evidence for Irritable Bowel Syndrome with Constipation (IBS-C)

Research exploring Linin for use in adults with Irritable Bowel Syndrome with Constipation (IBS-C) was primarily conducted using short-term, randomized, double-blind, placebo-controlled Phase 3 clinical trials. These studies are used by researchers to assess patterns by comparing outcomes in populations receiving the study drug versus those receiving an inactive substance (placebo).

In these studies, researchers monitored outcomes related to physical discomfort and bowel function. The main measure was a composite endpoint, where they looked for simultaneous change in abdominal pain severity and change in the frequency of complete, spontaneous bowel movements. Studies monitored patterns over assessment periods that usually lasted around 12 weeks.

2. Research Evidence for Chronic Idiopathic Constipation (CIC)

Research examined Linin in adults with Chronic Idiopathic Constipation (CIC). The studies were similar to the IBS-C research, involving short-term (12-week) controlled clinical trials. These studies focused mainly on monitoring bowel function, examining changes in the weekly frequency of spontaneous and complete spontaneous bowel movements, which are outcomes related to systemic or functional imbalance.

Research highlights changes measured during the study period related to bowel movement frequency in the short-term. Secondary evaluations also monitored how symptoms like abdominal discomfort evolved in the observed populations. Research explored specific subgroups, such as adult patients with CIC who also have Type 2 Diabetes.

3. Research in Specific Populations and Long-Term Data

The use of Linin was explored in specific pediatric age groups with Functional Constipation, primarily examining cohorts of children aged 6 to 17 years and 2 to 5 years. Research monitored the change in the weekly frequency rate of Spontaneous Bowel Movements.

For all indications, the follow-up durations were limited in the main controlled efficacy studies. While open-label extension studies provided data for up to 52 to 78 weeks, these longer-term studies do not have the same rigorous placebo-controlled design. This means long-term effects are not fully established regarding the durability of the observed changes, and comparative evidence is lacking for many potential comparisons.

Key Studies & References

  1. Linaclotide for chronic idiopathic constipation in patients with diabetes: a post hoc analysis of two randomized, placebo-controlled trials

Frequently Asked Questions (FAQ)

Common questions about Linin (FAQ)


Q: Is Linin a blood thinner or a type of painkiller?

A: According to official regulatory documents, Linin is classified as a Guanylate Cyclase-C (GC-C) agonist. This means it works locally in the gastrointestinal tract, primarily affecting fluid balance and the movement of contents. While it may influence pain-sensing nerves (nociceptors) in the gut, its official class is not that of a traditional blood thinner or systemic painkiller.


Q: Are there any common foods or drinks that should be avoided with Linin?

A: Official guidelines emphasize that Linin must be taken on an empty stomach, at least 30 minutes before the first meal of the day. This timing requirement is consistent with administration guidelines described in official product information. Taking the medicine at the same time as a high-fat meal may result in a higher occurrence of looser or more frequent stools.


Q: What is the list of side effects that people report most often with Linin?

A: The most frequently reported side effect in clinical studies is diarrhea, which regulatory bodies classify as a very common reaction. Other common reactions, affecting up to 1 in 10 people, include abdominal pain, abdominal distension (bloating), and flatulence. These are the most typical effects observed.


Q: How long does it usually take to feel the effects of Linin?

A: Clinical trials for regulatory approval typically observed changes in function over 12 weeks to assess the main outcomes. The most common side effect reported, diarrhea, was observed most frequently within the first two weeks of initiating therapy.


Q: Is it common to feel a little dizzy when first starting Linin?

A: Dizziness is not explicitly listed as a common side effect in the official safety profile. However, severe or prolonged diarrhea is an uncommon serious reaction that may lead to dehydration. Official guidance suggests that caution is warranted if dizziness occurs as a result of dehydration.


Q: Does taking Linin change how birth control pills work?

A: Official product information notes a risk of an indirect absorption interaction with oral medicinal products, including Oral Contraceptives. This is because Linin can accelerate the passage of contents through the gut, which could potentially reduce the time available for the body to absorb the co-administered medicine.


Q: What kind of studies were done to show how Linin works?

A: Official documents define the mechanism of action based on studies showing Linin acts locally as a highly selective Guanylate Cyclase-C (GC-C) agonist on the surface of intestinal cells. This mechanism involves triggering an internal signaling pathway that facilitates fluid secretion into the gastrointestinal tract.


Q: Is Linin considered a long-term treatment or short-term?

A: Efficacy studies for regulatory approval established benefit in trials lasting up to 6 months. In official product information, physicians are advised to periodically assess the continued need for the medicine, reflecting its use over time.


Q: Can Linin be taken alongside common over-the-counter allergy medicine?

A: Since Linin has minimal systemic absorption, official documents state that systemic pharmacokinetic interactions are not expected. However, co-administration with any medicine that changes bowel function could potentially increase the risk of diarrhea.


Q: Is the active ingredient in Linin synthetic or naturally derived?

A: The active ingredient, linaclotide, is officially described as a 14-amino acid synthetic peptide. This means it is a laboratory-made compound that is structurally related to a family of naturally occurring peptides known as guanylin.


Q: Why did my doctor choose Linin instead of a generic option?

A: Official drug product records show that a generic version of Linin (Linaclotide) for all approved dosage strengths is not currently available on the U.S. market. The availability of generic alternatives is a factor to consider.


Q: Is Linin known to cause stomach problems like nausea or heartburn?

A: Nausea is listed in regulatory sources as a common adverse reaction, affecting up to 1 in 10 patients in clinical trials. Abdominal pain is also a common complaint. Heartburn is not listed among the most frequently reported side effects.


Q: Is there a generic version of Linin available in the US?

A: Currently, no generic version of Linin (Linaclotide) for all approved dosage strengths is available on the U.S. market, according to the official FDA database.


Q: Can Linin be taken with a morning cup of coffee?

A: The medicine must be taken on an empty stomach at least 30 minutes before the first meal of the day. While official instructions do not specifically address all liquids, the primary requirement is that the drug must be administered on an empty stomach 30 minutes before the first meal.


Q: What is the estimated time frame for Linin to reach its full effect?

A: The main efficacy studies for both Irritable Bowel Syndrome with Constipation and Chronic Idiopathic Constipation measured the achievement of symptom change endpoints over a period of 12 weeks. This 12-week period is the established timeframe used in regulatory assessments.


Q: Are there any specific organs that Linin can affect over time?

A: Linin acts locally in the gastrointestinal tract due to its mechanism. Regulatory pharmacokinetic data confirm that the drug and its active metabolite have minimal systemic absorption, meaning they are minimally measurable in the bloodstream after administration of recommended doses.


Q: Does Linin interact with alcohol, even in small amounts?

A: Formal interaction studies with alcohol have not been conducted according to official sources. However, certain symptoms noted in the drug's safety profile, such as headache or dehydration, may be related to alcohol consumption.


Q: Is the headache side effect reported often by Linin users?

A: Headache is not listed among the very common or common adverse reactions in the official safety profile, meaning it was not reported by more than 1 in 10 people in clinical studies.


Q: Can you drive while you are taking Linin?

A: Official product information states that there are no known direct effects of the drug on the ability to drive or use machines. Official information indicates that if patients experience symptoms such as dizziness related to dehydration, caution should be used when driving or operating machinery.


Q: What is the half-life of Linin, in simple terms?

A: The half-life of Linin is not typically discussed in terms of standard systemic clearance. This is because the drug and its active metabolite are minimally detectable or not measurable in the plasma of adult patients after recommended oral doses, as the medicine acts locally within the GI tract.


Q: Can pregnant individuals be prescribed Linin?

A: Regulatory information indicates that because Linin is negligibly absorbed into the bloodstream, maternal use is not expected to result in fetal exposure. Current data from pregnant women are insufficient to fully inform any drug-associated risk for birth defects or miscarriage.


Q: Is it possible to be allergic to Linin?

A: Yes, serious hypersensitivity reactions (allergic-type reactions) are documented in regulatory sources as a rare Immune System Disorder. These reactions include serious swelling, known as angioedema, affecting the face, lips, or tongue.


Q: Does Linin interact with common painkillers like ibuprofen?

A: Official interaction documents indicate that co-administration with Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), a class that includes ibuprofen, may increase the risk of diarrhea. This is categorized as a potential interaction that affects the gut function.


Q: What happens if you accidentally take more Linin than prescribed?

A: Regulatory information on overdosage states that the most likely adverse event following the accidental ingestion of doses higher than prescribed is severe diarrhea. Regulatory guidance suggests that if this occurs, dosing should be suspended and rehydration should be pursued.


Q: How long does Linin stay in the system after the last dose?

A: Linin is proteolytically degraded locally within the GI tract. Because the drug has minimal systemic absorption, it is not measurable in the bloodstream after administration of recommended doses.


Q: Is there a different dosage of Linin for men vs women?

A: Dosing recommendations are defined based on the condition being treated and the patient's age (adults or pediatric groups). The official dosage recommendations are not differentiated by sex.


Q: Can Linin be taken without food?

A: The medicine is required to be taken on an empty stomach at least 30 minutes prior to the first meal of the day. Taking it with food is not recommended and can result in the occurrence of looser stools.


Q: What evidence supports the long-term use of Linin?

A: While the main controlled efficacy studies were short-term, data from open-label extension studies have provided follow-up information regarding patient experience for up to 52 to 78 weeks. However, the durability of effects is subject to periodic assessment by a physician.


Q: Does Linin have a risk evaluation and mitigation strategy (REMS)?

A: Linin is not classified with a full Risk Evaluation and Mitigation Strategy (REMS) program. However, the official FDA label includes a Boxed Warning that highlights the risk of serious dehydration in pediatric patients under 2 years of age.


Q: What are the most serious, but rare, side effects associated with Linin?

A: Serious adverse reactions that have been documented in regulatory sources include severe diarrhea, which may lead to dehydration, and serious hypersensitivity reactions (allergic reactions) such as angioedema (swelling).

How should Linin be stored and disposed of?

Official Storage and Disposal Instructions for Linin (Linaclotide)

Linin capsules must be stored according to regulatory specifications to ensure product stability and safety, focusing on temperature and moisture control.

Storage Requirements

Condition Regulatory Requirement
Temperature Store at controlled room temperature, 20 C to 25 C (68 F to 77 F).
Protection Keep the medicine in the original container, tightly closed, and protected from moisture; do not remove the desiccant.
Child Safety Keep out of the sight and reach of children using the child-resistant closure.
Stability Discard product 18 months after opening the bottle or after the printed expiration date.

Disposal

Unused or expired Linin must be disposed of according to local requirements. Do not dispose of the capsules by flushing them down a toilet or pouring them down a drain (wastewater) unless specifically instructed by a healthcare professional. Utilize a local drug take-back program when available.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Linin found in:

A-Z Index: